April 20, 2023 Non Regulatory Invitation to a presentation of the results from Promore Pharma’s clinical trial PHSU05
February 27, 2023 Non Regulatory Inbjudan till presentation av Promore Pharmas delårsrapport för Q4 2022
February 27, 2023 Non Regulatory Invitation to Conference Call regarding Promore Pharma’s Interim Report for the Fourth Quarter 2022
February 27, 2023 Non Regulatory Promore Pharma når milstolpen Clean File i sin kliniska fas II-studie med ensereptide
February 27, 2023 Non Regulatory Promore Pharma reaches the Clean File milestone in its phase II clinical trial with ensereptide
November 24, 2022 Non Regulatory Invitation to Conference Call regarding Promore Pharma’s Interim Report for the Third Quarter 2022
November 24, 2022 Non Regulatory Inbjudan till presentation av Promore Pharmas delårsrapport för Q3 2022
August 23, 2022 Non Regulatory Invitation to Conference Call regarding Promore Pharma’s Interim Report for the Second Quarter 2022
August 23, 2022 Non Regulatory Inbjudan till telefonkonferens om Promore Pharmas rapport för det andra kvartalet 2022
August 10, 2022 Non Regulatory Promore Pharma beviljas patent i Europa avseende behandling av kroniska sår
August 10, 2022 Non Regulatory Promore Pharma granted EU patent regarding treatment of chronic wounds
May 13, 2022 Non Regulatory Inbjudan till telefonkonferens om Promore Pharmas rapport för det första kvartalet 2022
May 13, 2022 Non Regulatory Invitation to Conference Call regarding Promore Pharma’s Interim Report for the First Quarter 2022
February 9, 2022 Non Regulatory Inbjudan till telefonkonferens med anledning av Promore Pharmas Bokslutskommuniké 2021
February 9, 2022 Non Regulatory Invitation to Conference Call regarding Promore Pharma’s Year-end Report 2021
December 8, 2021 Non Regulatory Promore Pharma beviljas patent i USA avseende behandling av kroniska sår
December 8, 2021 Non Regulatory Promore Pharma granted US patent regarding treatment of chronic wounds
November 19, 2021 Non Regulatory Invitation to Conference Call regarding Promore Pharma’s Interim Report for the Third Quarter 2021
November 19, 2021 Non Regulatory Inbjudan till telefonkonferens med anledning av Promore Pharmas rapport för det tredje kvartalet 2021
August 17, 2021 Non Regulatory Inbjudan till presentation av Promore Pharmas delårsrapport för Q2 2021
August 17, 2021 Non Regulatory Invitation to Conference Call regarding Promore Pharma’s Q2 Report 2021
May 26, 2021 Non Regulatory Promore Pharma participates in “Småbolagsdagarna 2021”, an event organized by Aktiespararna
February 16, 2021 Non Regulatory Inbjudan till presentation av Promore Pharmas bokslutskommuniké för 2020
February 16, 2021 Non Regulatory Invitation to Presentation of Promore Pharma’s Year-end report for 2020
November 20, 2020 Non Regulatory Inbjudan till telefonkonferens med anledning av Promore Pharmas rapport för det tredje kvartalet 2020
November 20, 2020 Non Regulatory Invitation to Conference Call regarding Promore Pharma’s Interim Report for the Third Quarter 2020
October 27, 2020 Non Regulatory Nomination Committee Appointed for the Annual General Meeting 2021 in Promore Pharma
August 19, 2020 Non Regulatory Inbjudan till presentation av Promore Pharmas delårsrapport för det andra kvartalet 2020
August 19, 2020 Non Regulatory Invitation to Presentation of Promore Pharma’s Interim Report for the Second Quarter 2020
May 25, 2020 Non Regulatory Invitation to Conference Call regarding Promore Pharma’s Interim Report for the First Quarter 2020
May 25, 2020 Non Regulatory Inbjudan till telefonkonferens med anledning av Promore Pharmas rapport för det första kvartalet 2020
February 13, 2020 Non Regulatory Invitation to Presentation of Promore Pharma’s Year-end report for 2019
February 13, 2020 Non Regulatory Inbjudan till presentation av Promore Pharmas bokslutskommuniké för 2019
October 17, 2019 Non Regulatory Nomination Committee Appointed for the Annual General Meeting 2020 in Promore Pharma
August 23, 2019 Non Regulatory Inbjudan till presentation av Promore Pharmas delårsrapport för det andra kvartalet 2019
August 23, 2019 Non Regulatory Invitation to Presentation of Promore Pharma’s Interim report for the second quarter 2019
May 15, 2019 Non Regulatory Invitation to Presentation of Promore Pharma’s Interim report for the first quarter 2019
February 20, 2019 Non Regulatory Invitation to Presentation of Promore Pharma’s Year-end report for 2018
February 20, 2019 Non Regulatory Inbjudan till presentation av Promore Pharmas bokslutskommuniké 2018
November 9, 2018 Non Regulatory Nomination Committee Appointed for the Annual General Meeting 2019 in Promore Pharma
September 6, 2018 Non Regulatory Promore Pharma has conducted Investigator Meeting for HEAL LL-37 in Poland
September 3, 2018 Non Regulatory Promore Pharma planerar att bredda den terapeutiska peptiden PXL01 att också inkludera ärrbildning på hud
September 3, 2018 Non Regulatory Promore Pharma Plans to Expand Indications of Therapeutic Peptide PXL01 in the Field of Dermal Scarring
August 14, 2018 Non Regulatory Invitation to Presentation of Promore Pharma’s Interim report for the second quarter 2018
August 14, 2018 Non Regulatory Inbjudan till presentation av Promore Pharmas rapport för andra kvartalet 2018
May 9, 2018 Non Regulatory Invitation to Presentation of Promore Pharma’s Interim report for the first quarter 2018
May 9, 2018 Non Regulatory Inbjudan till presentation av Promore Pharmas rapport för första kvartalet 2018
April 24, 2018 Non Regulatory Promore Pharma har lämnat underlag avseende investeraravdrag till Skatteverket
April 4, 2018 Non Regulatory Two new smart-phone based imaging products have been adopted by Promore Pharma AB
October 30, 2017 Non Regulatory Promore Pharma slutför ett omfattande europeiskt samarbete avseende DPK-060
October 30, 2017 Non Regulatory Promore Pharma Completes Extensive European Collaboration Regarding DPK-060
September 12, 2017 Non Regulatory Promore Pharma presents at the symposium for hard-to-heal wounds in connection with Nordic Life Science Days
September 12, 2017 Non Regulatory Promore Pharma presenterar på symposium för svårläkta sår i anslutning till Nordic Life Science Days
May 16, 2017 Non Regulatory Promore Pharma inlämnar ansökan om att genomföra en fas III-studie i Indien
April 26, 2017 Non Regulatory Promore Pharma utser Marianne Dicander Alexandersson till ny styrelseledamot och meddelar planer för notering på Nasdaq First North
April 26, 2017 Non Regulatory Promore Pharma AB elects Marianne Dicander Alexandersson as New Board Member and outlines plans for IPO
December 21, 2016 Non Regulatory Promore Pharma and Cellastra Inc. Announce Phase III Clinical Collaboration to Develop Therapeutic Peptide PXL01 for the US Market
July 8, 2016 Non Regulatory Promore Pharma Announces a Strategic Collaboration with Technomark Life Sciences
May 31, 2016 Non Regulatory Promore Pharma Obtains Positive Feedback in Dialogue with The Medical Products Agency of Sweden